ELOQUENT-2 Study in Japanese Patients - Safety was consistent with patients in relapsed refractory myeloma - 101931

Spotlight
Video

ELOQUENT-2 Study in Japanese Patients - Safety was consistent with patients in relapsed refractory myeloma

ASHReport has 256 videos Subscribe Here

Loading........
Description: Mitsuo Hori, MD from Ibaraki Prefectural Central Hospital discusses ELOQUENT-2 study in Japanese patients safety was consistent with patients in relapsed refractory myeloma at the 2017 American Society of Hematology.
Shared By : ASHReport
Posted on : 01/24/18
Added : 8 months ago
Category : Multiple Myeloma